BREAKING NEWS: Peptides are coming In July, the FDA is reviewing BPC 157, TB 500, Semax, Epitalon and more. The meeting will be open to the public. The peptide era begins. When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with